Pancreatic Cancer Research

ResearcherQingdao UniversityActive in the last 2 years

Wen Fu

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. WTAP/IGF2BP3-mediated GBE1 expression accelerates the proliferation and enhances stemness in pancreatic cancer cells via upregulating c-Myc. Co-author DOI 10.1186/s11658-024-00611-8↗
  2. UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ijo.2023.5500↗
  3. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.927640↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoge Hu · 3 shared papers, 2022–2024 · strength 0.56
  2. Qiuran Xu · 2 shared papers, 2022–2024 · strength 0.37
  3. Weiwei Jin · 1 shared paper, 2024 · strength 0.21
  4. Xiangmin Tong · 1 shared paper, 2023 · strength 0.19
  5. Kangsheng Tu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.